Candida auris infection

By | June 8, 2019

Centers for Disease Control and Prevention website. Candida auris. www.cdc.gov/fungal/candida-auris/index.html. Updated April 30, 2019. Accessed May 6, 2019.

Centers for Disease Control and Prevention website. Candida auris: A drug-resistant germ that spreads in healthcare facilities. www.cdc.gov/fungal/candida-auris/c-auris-drug-resistant.html. Updated: December 21, 2018. Accessed May 6, 2019.

Centers for Disease Control and Prevention website. Candida auris colonization. www.cdc.gov/fungal/candida-auris/fact-sheets/c-auris-colonization.html. Updated: December 21, 2018. Accessed May 6, 2019.

Centers for Disease Control and Prevention website. Candida auris information for patients and family members. www.cdc.gov/fungal/candida-auris/patients-qa.html. Updated: December 21, 2018. Accessed May 6, 2019.

Centers for Disease Control and Prevention website. Infection prevention and control for Candida auris. www.cdc.gov/fungal/candida-auris/c-auris-infection-control.html. Updated: December 21, 2018. Accessed May 6, 2019.

Centers for Disease Control and Prevention website. Treatment and management of infections and colonization. www.cdc.gov/fungal/candida-auris/c-auris-treatment.html. Updated: December 21, 2018. Accessed May 6, 2019.

Cortegiani A, Misseri G, Fasciana T, Giammanco A, Giarratano A, Chowdhary A. Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris. J Intensive Care. 2018;6:69. PMID: 30397481 www.ncbi.nlm.nih.gov/pubmed/30397481.

Jeffery-Smith A, Taori SK, Schelenz S, et al. Candida auris: a review of the literature. Clin Microbiol Rev. 2017;31(1). PMID: 29142078 www.ncbi.nlm.nih.gov/pubmed/29142078.

Sears D, Schwartz BS. Candida auris: an emerging multidrug-resistant pathogen. Int J Infect Dis. 2017;63:95-98. PMID: 28888662 www.ncbi.nlm.nih.gov/pubmed/28888662.

New Links on MedlinePlus

Read More:  FDA Approves Skyrizi (risankizumab-rzaa) for Moderate to Severe Plaque Psoriasis